Skip to main content
. Author manuscript; available in PMC: 2013 Jul 8.
Published in final edited form as: Ann Surg Oncol. 2008 May 21;15(8):2137–2145. doi: 10.1245/s10434-008-9967-1

TABLE 3.

Toxicities observed for patients by cohort

Toxicity 200 mg/M2
250 mg/M2
Grade 1 or 2
Grade 3+
Grade 1 or 2
Grade 3+
N % N % N % N %
Leukocytes 4 33 0 0 2 67 1 33
Platelets 6 50 1 8 0 0 2 67
Hemoglobin 2 17 2 17 0 0 2 67
Nausea 3 25 0 0 2 67 0 0
Vomiting 0 0 0 0 1 33 0 0
Diarrhea 1 8 0 0 2 67 0 0
Alkaline phosphatase 1 8 0 0 0 0 0 0
Neuropathy: sensory 0 0 0 0 1 33 0 0
Neutrophils/granulocytes 1 8 0 0 0 0 2 67
Calcium, serum-low 1 8 0 0 0 0 0 0
Bilirubin 1 8 0 0 0 0 0 0
AST, SGOT 0 0 1 8 0 0 0 0
Pain: abdomen NOS 0 0 1 8 0 0 0 0
Acidosis 0 0 0 0 0 0 1 33
Partial thromboplastin time 1 8 0 0 0 0 0 0
Liver dysfunction 0 0 0 0 1 33 0 0
Ileus, GI 1 8 0 0 0 0 1 33
Lymphopenia 3 25 9 75 0 0 3 100
Malabsorption 0 0 1 8 0 0 1 33
Infection with unknown ANC 0 0 1 8 0 0 0 0
Mucositis/stomatitis 0 0 0 0 1 33 0 0
Hemorrhage 0 0 0 0 0 0 1 33
Blood/bone marrow 0 0 0 0 0 0 1 33